Meaning of Better Scoring System for the Patients with Cancer Bleeding in the Upper Gastrointestinal Tract
Gut Liver. 2024 Mar 15;18(2):195-196. doi: 10.5009/gnl240091.NO ABSTRACTPMID:38481276 | PMC:PMC10938145 | DOI:10.5009/gnl240091 (Source: Gut and Liver)
Source: Gut and Liver - March 14, 2024 Category: Gastroenterology Authors: Ji Yong Ahn Source Type: research
Three-Step Algorithm for Screening High-Risk Group of Metabolic Dysfunction-Associated Steatotic Liver Disease in General Population
Gut Liver. 2024 Mar 15;18(2):197-198. doi: 10.5009/gnl240083.NO ABSTRACTPMID:38481277 | PMC:PMC10938154 | DOI:10.5009/gnl240083 (Source: Gut and Liver)
Source: Gut and Liver - March 14, 2024 Category: Gastroenterology Authors: Joo Hyun Oh Dae Won Jun Source Type: research
Optimal Follow-up of Incidental Pancreatic Cystic Lesions without Worrisome Features: The Follow-up Strategy Is Still Evolving
Gut Liver. 2024 Mar 15;18(2):199-200. doi: 10.5009/gnl240080.NO ABSTRACTPMID:38481278 | PMC:PMC10938155 | DOI:10.5009/gnl240080 (Source: Gut and Liver)
Source: Gut and Liver - March 14, 2024 Category: Gastroenterology Authors: Tae Yoon Lee Source Type: research
Meaning of Better Scoring System for the Patients with Cancer Bleeding in the Upper Gastrointestinal Tract
Gut Liver. 2024 Mar 15;18(2):195-196. doi: 10.5009/gnl240091.NO ABSTRACTPMID:38481276 | PMC:PMC10938145 | DOI:10.5009/gnl240091 (Source: Gut and Liver)
Source: Gut and Liver - March 14, 2024 Category: Gastroenterology Authors: Ji Yong Ahn Source Type: research
Three-Step Algorithm for Screening High-Risk Group of Metabolic Dysfunction-Associated Steatotic Liver Disease in General Population
Gut Liver. 2024 Mar 15;18(2):197-198. doi: 10.5009/gnl240083.NO ABSTRACTPMID:38481277 | PMC:PMC10938154 | DOI:10.5009/gnl240083 (Source: Gut and Liver)
Source: Gut and Liver - March 14, 2024 Category: Gastroenterology Authors: Joo Hyun Oh Dae Won Jun Source Type: research
Optimal Follow-up of Incidental Pancreatic Cystic Lesions without Worrisome Features: The Follow-up Strategy Is Still Evolving
Gut Liver. 2024 Mar 15;18(2):199-200. doi: 10.5009/gnl240080.NO ABSTRACTPMID:38481278 | PMC:PMC10938155 | DOI:10.5009/gnl240080 (Source: Gut and Liver)
Source: Gut and Liver - March 14, 2024 Category: Gastroenterology Authors: Tae Yoon Lee Source Type: research
Meaning of Better Scoring System for the Patients with Cancer Bleeding in the Upper Gastrointestinal Tract
Gut Liver. 2024 Mar 15;18(2):195-196. doi: 10.5009/gnl240091.NO ABSTRACTPMID:38481276 | PMC:PMC10938145 | DOI:10.5009/gnl240091 (Source: Gut and Liver)
Source: Gut and Liver - March 14, 2024 Category: Gastroenterology Authors: Ji Yong Ahn Source Type: research
Three-Step Algorithm for Screening High-Risk Group of Metabolic Dysfunction-Associated Steatotic Liver Disease in General Population
Gut Liver. 2024 Mar 15;18(2):197-198. doi: 10.5009/gnl240083.NO ABSTRACTPMID:38481277 | PMC:PMC10938154 | DOI:10.5009/gnl240083 (Source: Gut and Liver)
Source: Gut and Liver - March 14, 2024 Category: Gastroenterology Authors: Joo Hyun Oh Dae Won Jun Source Type: research
Optimal Follow-up of Incidental Pancreatic Cystic Lesions without Worrisome Features: The Follow-up Strategy Is Still Evolving
Gut Liver. 2024 Mar 15;18(2):199-200. doi: 10.5009/gnl240080.NO ABSTRACTPMID:38481278 | PMC:PMC10938155 | DOI:10.5009/gnl240080 (Source: Gut and Liver)
Source: Gut and Liver - March 14, 2024 Category: Gastroenterology Authors: Tae Yoon Lee Source Type: research
Meaning of Better Scoring System for the Patients with Cancer Bleeding in the Upper Gastrointestinal Tract
Gut Liver. 2024 Mar 15;18(2):195-196. doi: 10.5009/gnl240091.NO ABSTRACTPMID:38481276 | PMC:PMC10938145 | DOI:10.5009/gnl240091 (Source: Gut and Liver)
Source: Gut and Liver - March 14, 2024 Category: Gastroenterology Authors: Ji Yong Ahn Source Type: research
Three-Step Algorithm for Screening High-Risk Group of Metabolic Dysfunction-Associated Steatotic Liver Disease in General Population
Gut Liver. 2024 Mar 15;18(2):197-198. doi: 10.5009/gnl240083.NO ABSTRACTPMID:38481277 | PMC:PMC10938154 | DOI:10.5009/gnl240083 (Source: Gut and Liver)
Source: Gut and Liver - March 14, 2024 Category: Gastroenterology Authors: Joo Hyun Oh Dae Won Jun Source Type: research
Optimal Follow-up of Incidental Pancreatic Cystic Lesions without Worrisome Features: The Follow-up Strategy Is Still Evolving
Gut Liver. 2024 Mar 15;18(2):199-200. doi: 10.5009/gnl240080.NO ABSTRACTPMID:38481278 | PMC:PMC10938155 | DOI:10.5009/gnl240080 (Source: Gut and Liver)
Source: Gut and Liver - March 14, 2024 Category: Gastroenterology Authors: Tae Yoon Lee Source Type: research
Rebamipide Prevents the Hemoglobin Drop Related to Mucosal-Damaging Agents at a Level Comparable to Proton Pump Inhibitors
CONCLUSIONS: : Rebamipide, like PPIs, was highly effective in preventing blood hemoglobin level decreases, as shown in real-world data. Rebamipide could be a comprehensive strategy for protecting the entire GI tract, especially when considering PPIs' potential side effects on the lower GI tract.PMID:38468192 | DOI:10.5009/gnl230372 (Source: Gut and Liver)
Source: Gut and Liver - March 12, 2024 Category: Gastroenterology Authors: Ji Eun Kim Yeong Chan Lee Tae Se Kim Eun Ran Kim Sung Noh Hong Young-Ho Kim Kyunga Kim Dong Kyung Chang Source Type: research
